Your browser doesn't support javascript.
loading
Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells.
Ross, David M; Pagani, Ilaria S; Shanmuganathan, Naranie; Kok, Chung H; Seymour, John F; Mills, Anthony K; Filshie, Robin J; Arthur, Christopher K; Dang, Phuong; Saunders, Verity A; Braley, Jodi; Yong, Agnes S; Yeung, David T; White, Deborah L; Grigg, Andrew P; Schwarer, Anthony P; Branford, Susan; Hughes, Timothy P.
Afiliação
  • Ross DM; Cancer Theme, South Australian Health & Medical Research Institute, Adelaide, Australia. David.Ross@sa.gov.au.
  • Pagani IS; Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide, Australia. David.Ross@sa.gov.au.
  • Shanmuganathan N; School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, Australia. David.Ross@sa.gov.au.
  • Kok CH; Flinders University and Medical Centre, Adelaide, Australia. David.Ross@sa.gov.au.
  • Seymour JF; Australasian Leukaemia and Lymphoma Group, Melbourne, Australia. David.Ross@sa.gov.au.
  • Mills AK; Cancer Theme, South Australian Health & Medical Research Institute, Adelaide, Australia.
  • Filshie RJ; School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, Australia.
  • Arthur CK; Australasian Leukaemia and Lymphoma Group, Melbourne, Australia.
  • Dang P; Cancer Theme, South Australian Health & Medical Research Institute, Adelaide, Australia.
  • Saunders VA; Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide, Australia.
  • Braley J; School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, Australia.
  • Yong AS; Australasian Leukaemia and Lymphoma Group, Melbourne, Australia.
  • Yeung DT; Genetic and Molecular Pathology, Centre for Cancer Biology, SA Pathology, Adelaide, Australia.
  • White DL; School of Pharmacy and Medical Science, University of South Australia, Adelaide, Australia.
  • Grigg AP; Cancer Theme, South Australian Health & Medical Research Institute, Adelaide, Australia.
  • Schwarer AP; School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, Australia.
  • Branford S; Australasian Leukaemia and Lymphoma Group, Melbourne, Australia.
  • Hughes TP; Department of Haematology, Royal Melbourne Hospital and Peter MacCallum Centre, and University of Melbourne, Melbourne, Australia.
Leukemia ; 32(12): 2572-2579, 2018 12.
Article em En | MEDLINE | ID: mdl-30315232
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Mesilato de Imatinib / Antineoplásicos Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Mesilato de Imatinib / Antineoplásicos Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Austrália